Ginkgo Bioworks closes $99.1M bought-deal equity offering of 41.4M shares

Ginkgo Bioworks Holdings, Inc.

Bought deal of 41,383,877 shares at $2.4164/share; net proceeds ~$99.1M after expenses.
Underwriter granted 30-day option to purchase up to 6,207,581 additional shares at same price.
Proceeds offset $80M cash used for Bayer CropScience asset acquisition and strengthen balance sheet.
Offering closed on November 18, 2022; underwriter BTIG, LLC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.